Breadcrumb

The RI-MUHC Technology Platforms invite you to attend the Platform Expo Webinar on October 7, 2021.
The Translational Research in Respiratory Diseases Program (RESP) builds upon the success of the Meakins-Christie Laboratories and the Respiratory Epidemiology and Clinical Research Unit (RECRU) to...
The vision of the Injury Repair Recovery Program (IRR) is to provide leadership in research and development, resulting in breakthroughs in the management of personal injury and reduction of its...
The Infectious Diseases and Immunity in Global Health Program (IDIGH) unites expertise, resources and research strengths in infectious diseases, immunology and global health across three domains....
The MeDiC Program at the Research Institute of the McGill University Health Centre (RI-MUHC) integrates outstanding basic science, clinical and evaluative researchers who share the goal of...
The Child Health and Human Development Program (CHHD) was created after collective reflection in several key areas. Since early life events and factors have the potential to dictate lifelong human...
The Cardiovascular Health across the Lifespan Program (CHAL) includes fundamental, clinical and evaluative research platforms. Basic research in this program focuses on the study of biomarkers,...
The Cancer Research Program (CRP) benefits from new state-of-the-art facilities to conduct basic research at the Centre for Translational Biology, clinical cancer research at the Centre for...
The BRaIN Program at the Research Institute of McGill University Health Centre (MUHC) brings together over 125 neuroscientists, neurologists, ophthalmologists, psychiatrists, neurosurgeons...
Mr. Peter Kruyt(Chair)Ms. Mary-Anne Carignan(Vice-Chair)Mr. Pierre Lortie(Treasurer)Ms. Cinzia Raponi(Secretary)Dr. Miguel Burnier(Board member)Prof. Martha Crago(Board member)Dr. David...
Peter Kruyt, B. Comm., MBAChairman of the BoardCurrent rolesMr. Kruyt became Senior Advisor to Power Corporation of Canada in January 2018....